05.12.2014 • NewsChennaiNutraceuticalsR. Mukundan

Tata Chemicals Plans Pilot Plant for Nutraceuticals

India's Tata Chemicals plans to commission a 300 t/y pilot plant to produce nutraceuticals at its Chennai site at the beginning of 2015. The start-up will mark the company's entry into the business, and is part of its plan to increasingly focus on specialty and consumer products businesses. A scale-up to 1,000 t is planned. Products to be made at the Chennai facility include oligosaccharides and polyols.

At an event to promote a new book on Tata's history, managing director R. Mukundan said the Indian company has evolved from a commodities enterprise producing mainly inorganic chemicals to one that provides solutions to end-customers.

Tata Chemicals is today world's second largest soda ash producer and the largest salt manufacturer, Mukundan said, adding that it is "completely committed to Indian agriculture."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.